Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
- PMID: 1465616
- DOI: 10.1126/science.1465616
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
Abstract
Impaired immune responses occur frequently in cancer patients or in tumor-bearing mice, but the mechanisms of the tumor-induced immune defects remain poorly understood. In an in vivo murine colon carcinoma model (MCA-38), animals bearing a tumor longer than 26 days develop CD8+ T cells with impaired cytotoxic function, decreased expression of the tumor necrosis factor-alpha and granzyme B genes, and decreased ability to mediate an antitumor response in vivo. T lymphocytes from tumor-bearing mice expressed T cell antigen receptors that contained low amounts of CD3 gamma and completely lacked CD3 zeta, which was replaced by the Fc epsilon gamma-chain. Expression of the tyrosine kinases p56lck and p59fyn was also reduced. These changes could be the basis of immune defects in tumor-bearing hosts.
Comment in
-
Do tumor-altered T cells depress immune responses?Science. 1992 Dec 11;258(5089):1732-3. doi: 10.1126/science.1465609. Science. 1992. PMID: 1465609 No abstract available.
Similar articles
-
T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity.J Exp Med. 1995 Oct 1;182(4):1029-36. doi: 10.1084/jem.182.4.1029. J Exp Med. 1995. PMID: 7561676 Free PMC article.
-
CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9311-5. doi: 10.1073/pnas.89.19.9311. Proc Natl Acad Sci U S A. 1992. PMID: 1384049 Free PMC article.
-
T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.J Immunol. 1995 Aug 1;155(3):1382-92. J Immunol. 1995. PMID: 7636203
-
The roles of CD8 in cytotoxic T lymphocyte function.Immunol Today. 1993 Apr;14(4):183-8. doi: 10.1016/0167-5699(93)90283-q. Immunol Today. 1993. PMID: 8499079 Review.
-
Signal transduction mediated by the T-cell antigen receptor.Ann N Y Acad Sci. 1995 Sep 7;766:157-72. doi: 10.1111/j.1749-6632.1995.tb26659.x. Ann N Y Acad Sci. 1995. PMID: 7486652 Review. No abstract available.
Cited by
-
Challenges and future perspectives of T cell immunotherapy in cancer.Immunol Lett. 2015 Aug;166(2):117-33. doi: 10.1016/j.imlet.2015.05.018. Epub 2015 Jun 19. Immunol Lett. 2015. PMID: 26096822 Free PMC article. Review.
-
T cell avidity and tumor recognition: implications and therapeutic strategies.J Transl Med. 2005 Sep 20;3:35. doi: 10.1186/1479-5876-3-35. J Transl Med. 2005. PMID: 16174302 Free PMC article.
-
Therapeutic vaccination with tumor cells that engage CD137.J Mol Med (Berl). 2003 Feb;81(2):71-86. doi: 10.1007/s00109-002-0413-8. Epub 2003 Feb 8. J Mol Med (Berl). 2003. PMID: 12601523 Review.
-
T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma.Gut. 1997 Jan;40(1):113-9. doi: 10.1136/gut.40.1.113. Gut. 1997. PMID: 9155587 Free PMC article.
-
Transfected lymphocyte extracts of patients with urological tumours: complement temperature-sensitive adenovirus mutants in vitro.Int Urol Nephrol. 1994;26(4):361-73. doi: 10.1007/BF02768003. Int Urol Nephrol. 1994. PMID: 8002206
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials